Photo-activated 5-hydroxyindole-3-acetic acid induces apoptosis of prostate and bladder cancer cells

Journal of Photochemistry and Photobiology B: Biology

Volumn 103, Issue 1, 2011, Pages 50-56

  Jeong, Yun Mi ^a   Li, Hailan ^a   Kim, Su Yeon ^a   Park, Woo Jae ^a   Yun, Hye Young ^a   Baek, Kwang Jin ^a   Kwon, Nyoun Soo ^a   Jeong, Ji Hoon ^a   Myung, Soon Chul ^a   Kim, Dong Seok ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

5 Hydroxyindole 3 acetic acid; Apoptosis; Bladder cancer; Prostate cancer; Ultraviolet B

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CASPASE 3; CASPASE 8; CASPASE 9; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOTOSENSITIZING AGENT; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER THERAPY; CARCINOMA CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL VIABILITY; CYTOTOXICITY; DOSE RESPONSE; HUMAN; HUMAN CELL; MALE; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ULTRAVIOLET B RADIATION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; G0 PHASE; G1 PHASE; HUMANS; INDOLES; LIGHT; MALE; PHOTOSENSITIZING AGENTS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 79952183866     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2011.01.011     Document Type: Article

References (24)

1. J.P. Van Brussel, G.H. Mickisch, Circumvention of multidrug resistance in genitourinary tumors, Int. J. Urol. 5 (1998) 1-15.
2. T. Kakizoe, L.A. Mucci, P.C. Albertsen, M.J. Droller, Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease, Scand. J. Urol. Nephrol. Suppl. (2008) 191-212.
3. O. Ogunyemi, A. Rojas, K. Hematpour, D. Rogers, C. Head, C. Bennett, Metastasis of genitourinary tumors to the head and neck region, Eur. Arch. Otorhinolaryngol. 267 (2010) 273-279.
4. T.Y. Chun, Coincidence of bladder and prostate cancer, J. Urol. 157 (1997) 65-67. (Pubitemid 26414929)
5. F. Barbisan, R. Mazzucchelli, M. Scarpelli, A. Lopez-Beltran, L. Cheng, Z. Kirkali, R. Montironi, Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? BJU Int. 103 (2009) 1058-1063.
6. X. Ma, H. Pan, J. Yi, Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment, Med. Hypotheses 72 (2009) 418-420.
7. S.C. Chang, S.G. Bown, Photodynamic therapy: applications in bladder cancer and other malignancies, J. Formos. Med. Assoc. 96 (1997) 853-863.
8. C. Adam, G. Salomon, S. Walther, D. Zaak, W. Khoder, A. Becker, O. Reich, A. Blana, R. Ganzer, S. Denzinger, G. Popken, R. Sroka, R. Knuchel-Clarke, J. Kollermann, G. Sauter, A. Hartmann, S. Bertz, M. Graefen, H. Huland, W. Wieland, C.G. Stief, Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure, Eur. Urol. 55 (2009) 1281-1288.
9. M. Burger, C.G. Stief, D. Zaak, A. Stenzl, W.F. Wieland, D. Jocham, W. Otto, S. Denzinger, Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors, Urology 74 (2009) 1282-1286.
10. Z. Xiao, Y. Tamimi, K. Brown, J. Tulip, R. Moore, Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid, Urol. Oncol. 7 (2002) 125-132.
11. K.C. Park, S.Y. Kim, D.S. Kim, Experimental photodynamic therapy for liver cancer cell-implanted nude mice by an indole-3-acetic acid and intense pulsed light combination, Biol. Pharm. Bull. 32 (2009) 1609-1613.
12. D.S. Kim, S.Y. Kim, Y.M. Jeong, S.E. Jeon, M.K. Kim, S.B. Kwon, J.I. Na, K.C. Park, Light-activated indole-3-acetic acid induces apoptosis in G361 human melanoma cells, Biol. Pharm. Bull. 29 (2006) 2404-2409.
13. S.Y. Kim, M.K. Kim, S.B. Kwon, J.I. Na, K.C. Park, D.S. Kim, Tumor apoptosis by indole-3-acetic acid/light in B16F10 melanoma-implanted nude mice, Arch. Dermatol. Res. 301 (2009) 319-322.
14. V. De Souza Moreno, K.C. Bicego, R.E. Szawka, J.A. Anselmo-Franci, L.H. Gargaglioni, Serotonergic mechanisms on breathing modulation in the rat locus coeruleus, Pflugers Arch. 459 (2010) 357-368.
15. Y.M. Jeong, J.E. Lee, S.Y. Kim, H.Y. Yun, K.J. Baek, N.S. Kwon, D.S. Kim, Enhanced effects of citrate on UVB-induced apoptosis of B16 melanoma cells, Pharmazie 64 (2009) 829-833.
16. E.F. Wagner, A.R. Nebreda, Signal integration by JNK and P38 MAPK pathways in cancer development, Nat. Rev. Cancer 9 (2009) 537-549.
17. V.L. Dawson, T.M. Dawson, Deadly conversations: nuclear-mitochondrial cross-talk, J. Bioenerg. Biomembr. 36 (2004) 287-294.
18. U.O. Nseyo, D.L. Lamm, Immunotherapy of bladder cancer, Semin. Surg. Oncol. 13 (1997) 342-349. (Pubitemid 27332857)
19. E. Rodriguez, P. Baas, J.S. Friedberg, Innovative therapies: photodynamic therapy, Thorac. Surg. Clin. 14 (2004) 557-566. (Pubitemid 39314490)
20. J.E. Damber, G. Aus, Prostate cancer, Lancet 371 (2008) 1710-1721. (Pubitemid 351671887)
21. D.C. Skinner, A.J. Albertson, A. Navratil, A. Smith, M. Mignot, H. Talbott, N. Scanlan-Blake, Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis, J. Neuroendocrinol. 21 (2009) 282-292.
22. D.S. Kaufman, W.U. Shipley, A.S. Feldman, Bladder cancer, Lancet 374 (2009) 239-249.
23. S. Fulda, Caspase-8 in cancer biology and therapy, Cancer Lett. 281 (2009) 128-133.
24. L.A. Allan, P.R. Clarke, Apoptosis and autophagy: regulation of caspase-9 by phosphorylation, FEBS J. 276 (2009) 6063-6073.